Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-Platelet Study: Ticagrelor vs Clopidogrel in CKD
NCT03649711Phase 3Completed
- Sponsor
- University of Arkansas
- Start
- Nov 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in myocardial infarction (MI), ischemic stroke, sponsored by University of Arkansas. Started Nov 2018; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)ischemic stroke
Beyond the preview
Go deeper on NCT03649711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649711.